Surmodics, Inc. (SRDX)
NASDAQ: SRDX · Real-Time Price · USD
39.33
+0.14 (0.36%)
At close: Nov 22, 2024, 4:00 PM
39.28
-0.05 (-0.13%)
After-hours: Nov 22, 2024, 4:14 PM EST
Surmodics Market Cap
Surmodics has a market cap or net worth of $563.44 million as of November 22, 2024. Its market cap has increased by 19.93% in one year.
Market Cap
563.44M
Enterprise Value
556.57M
1-Year Change
19.93%
Ranking
Category
Stock Price
$39.33
Market Cap Chart
Since December 1, 1998, Surmodics's market cap has increased from $67.50M to $563.44M, an increase of 734.73%. That is a compound annual growth rate of 8.51%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 21, 2024 | 561.40M | 9.09% |
Dec 29, 2023 | 514.60M | 7.43% |
Dec 30, 2022 | 479.00M | -28.45% |
Dec 31, 2021 | 669.50M | 12.48% |
Dec 31, 2020 | 595.20M | 6.04% |
Dec 31, 2019 | 561.30M | -11.36% |
Dec 31, 2018 | 633.20M | 72.63% |
Dec 29, 2017 | 366.80M | 9.33% |
Dec 30, 2016 | 335.50M | 27.86% |
Dec 31, 2015 | 262.40M | -7.67% |
Dec 31, 2014 | 284.20M | -15.16% |
Dec 31, 2013 | 335.00M | 2.20% |
Dec 31, 2012 | 327.80M | 27.55% |
Dec 30, 2011 | 257.00M | 23.97% |
Dec 31, 2010 | 207.30M | -47.64% |
Dec 31, 2009 | 395.90M | -11.31% |
Dec 31, 2008 | 446.40M | -54.99% |
Dec 31, 2007 | 991.70M | 73.25% |
Dec 29, 2006 | 572.40M | -16.56% |
Dec 30, 2005 | 686.00M | 19.85% |
Dec 31, 2004 | 572.40M | 38.03% |
Dec 31, 2003 | 414.70M | -16.41% |
Dec 31, 2002 | 496.10M | -18.92% |
Dec 31, 2001 | 611.90M | 0.02% |
Dec 29, 2000 | 611.80M | 163.59% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Mereo BioPharma Group | 580.87M |
Humacyte | 571.29M |
Corvus Pharmaceuticals | 566.09M |
Third Harmonic Bio | 563.23M |
Ironwood Pharmaceuticals | 556.90M |
Annexon | 554.82M |
GRAIL | 552.06M |
Omeros | 548.78M |